Summary
Theophylline clearance values in South African children were determined using 400 serum theophylline concentration measurements gathered from 109 compliant outpatients during their normal routine care. Population pharmacokinetic analysis was done using the Non-Linear Mixed Effects Model (Nonmem) to analyse the data. Nonmem was also used to estimate the influence of fixed effects (weight, age, race, gender etc) on clearance and its interindividual variability.
Gender, age, and weight raised to an iterated exponent were found to be the most important demographic fixed effect parameters influencing clearance. Race was not found to be important. The weight-adjusted values of theophylline clearance decreased with increasing age. The actual values expressed in l·h−1·kg−1 were 0.0949 for children aged 1–5 y; 0.0813 for children aged 5–9 y, and 0.0660 for children of 9–16 y. The values are similar to those reported in other studies.
Similar content being viewed by others
References
Al-Banna MK, Kelman AW, Whiting B (1989) Experimental design for optimal estimation of population pharmacokinetic parameters. Europ J Clin Pharmacol 36: A229
Aranda JV, Grondin D, Sasynick BI (1981) Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin North Am 28: 113–133
Arnold JD, Hill GN, Sansom LN (1981) A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission. Eur J Clin Pharmacol 20: 443–447
Beal SL (1984) Population pharmacokinetic data parameter estimation based on their first two statistical moments. Drug Metab Rev 15: 173–193
Beal SL, Sheiner LB (1980) The NONMEM System. Am Statistician 34: 118–119
Beal SL, Sheiner LB (1982) Estimating population kinetics. CRC Crit Rev Biomed Eng 8: 195–222
Beal SL, Sheiner LB (1989) NONMEM Users Guide, Part I: Users Basic Guide. Technical Report. Division of Clinical Pharmacology, University of California, San Francisco
Beal S, Boeckmann AJ, Sheiner LB (1990) NONMEM Users Guide. Part VI: PREDPP Guide. Technical Report. Division of Clinical Pharmacology, University of California, San Franscisco
Boeckman AJ, Beal SL, Sheiner LB (1989) NONMEM Users Guide, Part V, NM-TRAN Guide. Technical Report. Division of Clinical Pharmacology. University of California, San Francisco
Brandstetter Y, Kaplanski J, Leibson V, Ben-Zvi Z (1986) The effects of estrus cycle on drug metabolism in the rat. Eur J Drug Metab Pharmacokinet 11: 251–254
Dahlqvist R, Bertilisson L, Birkett DJ, Eichelbaum M, Saew J, Sjoqvist F (1984) Theophylline metabolism in relation to antiyprine, debrisoquine and sparteine metabolism. Clin Pharmacol Ther 35: 170–182
Driscoll MS, Ludden TM, Casto DT, Littlefield LC (1989) Evaluation of theophylline pharmacokinetics in a paediatric population using Mixed Effects Models. J Pharmakokinet Biopharm 17: 359–389
Ellis EF, Koysooko R, Levi G (1976) Pharmacokinetics of theophylline in children with asthma. Pediatrics 58: 542–547
Gardner MJ, Jusko WJ (1982) Effects of age and sex on theophylline clearance in premature infants with apnea. J Pediatr 89: 829–832
Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker Inc, New York
Ginchansky E, Weinberger M (1977) Relationship of theophylline clearance to oral dosage in children with chronic asthma. J Pediatr 91: 655–660
Grevel J, Whiting B, Kelman AW, Taylor WB, Bateman DN (1988) Population analysis of the pharmacokinetic variability of high-dose metoclopramide in cancer patients. Clin Pharmacol Ther 14: 52–63
Haltom JR, Szefler SJ (1985) Theophylline absorption in young asthmatic children receiving sustained release formulations. J Pediatr 107: 805–810
Hendeles L, Weinberger M (1983) Theophylline A “State of the Art” Review. Pharmacotherapy 3: 2–44
Hendeles L, Vaughan M, Weinberger M, Smith G (1981) Influence of gender on theophylline dosage requirements in children with chronic asthma. Drug Intel Clin Pharmacy 15: 338–340
Inaba T, Lucassen M, Kalow W (1980) Antipyrine Metabolism in the rat by three hepatic mono-oxygenases. Life Sci 26: 1977–1983
Isles a, Spino M, Tabachnik et al. (1981) Theophylline disposition in cystic fibrosis. Am Rev Respir Dis 127: 417–421
Joad JP, Ahrens MD, Lindgren SD et al. (1986) Extrapulmonary effects of maintenance therapy with theophylline and inhaled albuterol in patients with chronic asthma. J Allergy Clin Immunol 78: 1147–1153
Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors affecting theophylline clearance: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68: 1358–1366
Kellerman G, Luyten-Kellerman, Horning M, Stafford M (1976) Elimination of antipyrine and benzo(a)pyrene metabolism in cultured human lymphocytes. Clin Pharmacol Ther 20: 72–80
Lenter C (1984) Geigy Scientific Tables. Volume 3. 8th ed. Switzerland: Ciba-Geigy Ltd
Leung P, Kalisker A, Bell TD (1977) Variation in theophylline clearance in young subjects. J Allergy Clin Immunol 59: 440–444
Loughnan PM, Sitar DS, Olgilvie RF et al. (1976) Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 88: 874–879
Mc Laughlin J, Nall M, Isaaca B et al. (1983) The relationships of allergies and allergy treatment to school performance and student behaviour. Ann Allergy 51: 506–510
Mungall D, Ludden TM, Marshall J (1985) Population pharmacokinetics of racemic warfarin in adult patients. J Pharmacokinet Biopharm 13: 213–227
Murphy MB, Dillon A, Fitzgerald MX (1980) Theophylline and depression. Br Med J 281: 1322
Nafziger AN, Bertino JS (1989) Sex-related differences in theophylline pharmacokinetics. Eur J Clin Pharmacol 37: 97–100
O'Malley K, Crooks J, Duke E, Stevenson IH (1971) Effect of age and sex on human drug metabolism. Br Med J 3: 607–609
Pedersen S, Moller-Petersen J (1984) Erratic absorption of a slow release theophylline sprinkle product caused by food. Pediatrics 74: 634–638
Rachelefsky GS, Wo J, Addson J et al. (1986) Behaviour abnormalities and poor school performance due to oral theophylline. Pediatrics 78: 1133–1138
Rapport L, Coffman H, Guare R, Fenton T, de Graw C, Twarag F (1989) Effects of theophylline on behaviour and learning in children with asthma. Am J Dis Child 143: 368–372
Reister EF, Pantuck EJ, Pantuck CB, Passananti GT, Vessell ES, Conney AH (1980) Antipyrine metabolism during the menstrual cycle. Clin Pharmacol Ther 28: 384–391
Sheiner LB, Rosenberg B, Melmon KL (1972) Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res 5: 441–459
Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Clin Pharmacokinet Biopharm 5: 445–479
Springer C, Goldberg B, Ben Dou I et al. (1985) Clinical physiologic and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. J Allergy Clin Immunol 76: 64–69
Teunissen MWE, Srivastave AK, Breimer DD (1982) Influence of sex and oral contraceptive steroids on antipyrine metabolite formation. Clin Pharmacol Ther 24: 1361
Upton RA, Sansom L, Guentert TW et al. (1980) Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. J Pharmacokinet Biopharm 8: 229–242
Weinberger M, Ginchansky E (1977) Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr 91: 820–824
Weinberger M, Hendeles L, Bighley L (1978) The relation of product formulation to absorption of oral theophylline. N Engl J Med 229: 852–857
Weinberger M, Lindgren S, Bender B et al. (1987) Effects of theophylline on learning and behaviour: Reason for concern or concern without reason. J Pediatr 111: 471–474
Whiting B, Kelman AW, Grevel J (1986) Population pharmacokinetics. Theory and clinical application. Clin Pharmacokinet 11: 387–401
Wilson K (1984) Sex-related differences in drug disposition in man. Clin Pharmacokinet 9: 189–202
Zaske DE, Miller KW, Strem EL, Austrian S, Johnson PB (1977) Oral aminophylline therapy. Increased dosage requirements in children. J Am Med Assoc 237: 1453–1455
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Botha, J.H., Tyrannes, I., Miller, R. et al. Determination of theophylline clearance in South African children. Eur J Clin Pharmacol 44, 369–375 (1993). https://doi.org/10.1007/BF00316475
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00316475